Russian vaccine all set for approval this week
Coronavirus cases are increasing day by day across the world. Untill now it's vaccine is not yet available. More than 100 teams in the world are working day and night in search of the vaccine, so that the drug arrives and production starts at the earliest.
Russia may acquire the world's first coronavirus vaccine
It is being said that a Russian vaccine is being jointly prepared by the Gamaleya National Research Center and the Defense Ministry. The World Health Organization (WHO) has advised Russia to develop this vaccine according to its stated standards for safe and effective vaccines.
The World Health Organization has re-invited countries around the world to join the COVAX Facilitation Center. The objective of the facility is to increase international cooperation to develop the vaccine early so that it is available to all countries.
The countries joining the initiative are also assured of vaccine delivery when they become successful. The countries will be assured of supplies to protect at least 20 percent of their population.
Last week's agreement between the Pune-based Serum Institute of India and Bill and Melinda Gates Foundation to produce 100 million doses of the vaccine for low- and middle-income countries was part of the COVAX mechanism. These 100 million doses would be provided to eligible countries at a cost of US $3 per dose. Bill and Melinda Gates Foundation agreed to provide US $150 million in Serum to rapidly increase production capacity.
The Russian vaccine could be approved this week
Judging by earlier announcements from Russia, the coronavirus vaccine, being developed by the Gamaleya Institute in Moscow, is expected to be approved this week. It would be the first coronavirus vaccine to receive approval for public use, although a Chinese vaccine has already been approved for "limited use". The Chinese vaccine is currently only used on military personnel.
Russia has previously said that the vaccine would be approved on Aug 12 and be available for public use in September.
The super-fast speed at which it has been produced - other candidates are unlikely to appear on the horizon at least before the end of the year.
Russia claims this was made possible because the Coronavirus vaccine in development is very similar to a vaccine for Middle Eastern Respiratory Syndrome (MERS) disease caused by another coronavirus, which has already been extensively tested.
- More than 160 vaccine candidates in pre-clinical or clinical studies.
- 23 of them in clinical trials.
- Six in final stages, phase III of human trials.
- At least eight vaccine candidates are being developed in India.
- Two of these entered Phase II trials after completing Phase I.
- The first phase of the clinical trial of Hyderabad-based Bharat Biotech's Corona vaccine has been completed and now the second phase is being prepared.
Two companies in India compete for Coronavirus vaccine
Two Indian companies are vying for the Corona vaccine. One of them is Bharat Biotech Company and the other is Zydus Cadila. Zydus Cadila has developed a DNA based vaccine. This vaccine received approval for the human trial on 3 July. At the same time, Bharat Biotech has completed the first phase of the trial and is now preparing for the second phase of the trial.
Vaccine may come by the end of 2020
Adar Poonawala, CEO of Serum Institute of India (SII), Pune in Maharashtra, has said that the coronavirus vaccine may be ready by the end of this year, while its price will be announced in the next two months.
Bharat Biotech Company, which is trying to develop the Coronavirus vaccine, says that it does not want to work under pressure on it. The company's CMD Krishna Ella said that the current situation has put pressure on the company to produce the vaccine at the earliest, but we do not want to rush into it and there will be no compromise on safety and quality. CMD said that we do not want more people to die from the wrong vaccine.
Turkey also ready with a vaccine? President said claiming - "We are the third country to do so".
Turkish President Recep Tayyip Erdogan has claimed that Turkey has also developed a localized coronavirus vaccine after the US and China. Erdogan said that Turkey has become the third country in the world to do so. It is being told that this Turkish vaccine has received ethical approval and now clinical trials will be done on humans.
Coronavirus vaccine being made in Saudi Arabia as well, trial reached third phase
In the midst of the Coronavirus crisis, many countries of the world are working fast to make vaccines. Currently more than 100 teams are working for it. Meanwhile, Saudi Arabia is also said to be starting a third phase trial of CanSino's Coronavirus vaccine. This drug will be tested on about five thousand people, which is being prepared by CanSino Biologics Inc of China. This information was given by a spokesman of Saudi's Ministry of Health on Sunday. In July, the founder of CanSino said that the company was in talks with Russia, Brazil, Saudi and Chile to launch the third phase of the vaccine (Ad5-nCOV) trial.
Initial clinical trials for the Covid-19 vaccine have begun in Singapore and the first vaccine may be given to those involved in the trial next week. The vaccine, developed by Duke-NUS Medical School and US pharmaceutical company Arcturus Therapeutics, has been named 'Lunar-Cove 19', according to 'Straits Times' news.
Development of vaccine is going on from America to Africa
From the US, the UK, Brazil to South Africa, many countries are developing the Coronavirus vaccine. The Oxford-AstraZeneca vaccine is expected to arrive by November this year. It is undergoing trials at 18 locations in India. It consists of 1600 volunteers. It can be priced at Rs 225 per dose. It will be the cheapest vaccine in the world.